Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Simmons

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Advances in Experimental Medicine and Biology|July 26, 2013
Filovirus entryGraham Simmons
Viruses|March 31, 2019
Antiviral Functions of Monoclonal Antibodies against Chikungunya VirusJing Jin, Graham Simmons
Current Gene Therapy|January 21, 2016
Pseudotyping Viral Vectors With Emerging Virus Envelope ProteinsImke Steffen, Graham Simmons
Clinical and Vaccine Immunology : CVI|May 27, 2016
Inhibitory Antibodies Targeting Emerging Viruses: Advancements and MechanismsJing Jin, Graham Simmons
Expert Review of Anti-Infective Therapy|December 4, 2012
Development of novel entry inhibitors targeting emerging virusesYanchen Zhou, Graham Simmons
Journal of Virology|October 12, 2007
Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivityRachel L Kaletsky, Graham Simmons, Paul Bates
Advances in Experimental Medicine and Biology|October 14, 2006
Proteolysis of SARS-associated coronavirus spike glycoproteinGraham Simmons, Andrew J Rennekamp, Paul Bates
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2018
Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus EpidemicsGraham Simmons, Mars Stone, Michael P Busch
The Journal of General Virology|November 22, 2000
T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropismNathalie Dejucq, Graham Simmons, Paul R Clapham
Antiviral Research|October 15, 2013
Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral researchGraham Simmons, Pawel Zmora, Stefanie Gierer, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Advances in Experimental Medicine and Biology|July 26, 2013
Filovirus entryGraham Simmons
Viruses|March 31, 2019
Antiviral Functions of Monoclonal Antibodies against Chikungunya VirusJing Jin, Graham Simmons
Current Gene Therapy|January 21, 2016
Pseudotyping Viral Vectors With Emerging Virus Envelope ProteinsImke Steffen, Graham Simmons
Clinical and Vaccine Immunology : CVI|May 27, 2016
Inhibitory Antibodies Targeting Emerging Viruses: Advancements and MechanismsJing Jin, Graham Simmons
Expert Review of Anti-Infective Therapy|December 4, 2012
Development of novel entry inhibitors targeting emerging virusesYanchen Zhou, Graham Simmons
Journal of Virology|October 12, 2007
Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivityRachel L Kaletsky, Graham Simmons, Paul Bates
Advances in Experimental Medicine and Biology|October 14, 2006
Proteolysis of SARS-associated coronavirus spike glycoproteinGraham Simmons, Andrew J Rennekamp, Paul Bates
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2018
Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus EpidemicsGraham Simmons, Mars Stone, Michael P Busch
The Journal of General Virology|November 22, 2000
T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropismNathalie Dejucq, Graham Simmons, Paul R Clapham
Antiviral Research|October 15, 2013
Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral researchGraham Simmons, Pawel Zmora, Stefanie Gierer, et al.
Pageof 13